← All sarcoma trials
Recruiting nowN/AAges 18 Years and up

SAVE Studie- SArcoma Surgery With Vacuum Enhanced Wound Treatment Randomised Study to Evaluate the Wound Management in Sarcoma Surgery

Sponsor: Universitätsklinikum Hamburg-Eppendorf · NCT06889532 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Soft Tissue Sarcoma (STS)

What it tests

  • Intervention Group: In this group, a vacuum-assisted closure (VAC) system is applied intraoperatively to seal the wound, followed by a secondary closure after 3-7 days.procedure

Where it's running1 site

1 international site

  • Universitätsklinikum Hamburg Eppendorf

    Hamburg, Free and Hanseatic City of Hamburg, Germany 20246

    Recruiting now
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

Patients must be over 18 years old.

* Patients of any gender and background can be included.
* The largest tumor diameter on imaging must be at least 5 cm. Preoperative imaging is required to assess tumor dimensions.
* Sarcomas must be located in the lower extremity or groin.
* Cases must be discussed preoperatively at an interdisciplinary tumor board.
* Patients must provide informed consent to participate in the study.

Exclusion Criteria:

* Tumors smaller than 5 cm and superficial masses.
* Patients with local recurrences or prior wound healing complications in the surgical area.
* Patients with ulcerating or infected tumors, or those requiring emergency surgery.
* Other Soft Tissue Tumors such as Kaposi sarcoma.
* for whom direct closure is not possible during the initial surgery due to the extent of resection.

Updated 2025-03-21 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.